Rectal cancer - 5-year survival

The relative survival rate of rectal cancer patients treated at IRA II is 78.7% compared to 66.2% for the average Belgian institution.

These results are standardized on the basis of sex, age, cTNM, WHO score, and whether or not radical resection was performed. This difference is highly statistically significant according to the Cancer Registry Foundation.


Download here the report of the Belgian Cancer Registry